Deflazacort
![]() |
|
Systematic (IUPAC) name | |
---|---|
(11β,16β)-21-(acetyloxy)-11-hydroxy-2′-methyl-5′H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration |
Oral |
Pharmacokinetic data | |
Protein binding | 40% |
Metabolism | By plasma esterases, to active metabolite |
Biological half-life | 1.1–1.9 hours (metabolite) |
Excretion | Renal (70%) and fecal (30%) |
Identifiers | |
CAS Number | 14484-47-0 ![]() |
ATC code | H02AB13 (WHO) |
PubChem | CID: 26709 |
ChemSpider | 164861 ![]() |
UNII | KR5YZ6AE4B ![]() |
KEGG | D03671 ![]() |
ChEMBL | CHEMBL1201891 ![]() |
Chemical data | |
Formula | C25H31NO6 |
Molecular mass | 441.517 g/mol |
|
|
|
|
![]() ![]() |
Deflazacort is a glucocorticoid used as an anti-inflammatory and immunosuppressant.
Deflazacort is an inactive prodrug which is metabolized rapidly to the active drug 21-desacetyldeflazacort.[1] Its potency is around 70–90% that of prednisone.[2]
It is sold in Bangladesh as Xalcort, marketed by Beacon Pharmaceuticals Limited, in the United Kingdom by Shire under the trade name Calcort;[2] in Brazil as Cortax, Decortil, and Deflanil; in India as MOAID, Defolet(Roussette), DFZ, Decotaz, and DefZot; in Panama as Zamen, Spain as Zamene and in Honduras as Flezacor.[3] It is not available in the United States. In January 2015, the FDA granted fast track status to Marathon Pharmaceuticals to pursue approval of deflazacort as a potential treatment for Duchenne muscular dystrophy. The company expects to make deflazacort available in the United States in 2016. [4]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 Lua error in package.lua at line 80: module 'strict' not found. Retrieved on October 28, 2008.
- ↑ Lua error in package.lua at line 80: module 'strict' not found. Retrieved on October 28, 2008.
- ↑ http://www.chicagotribune.com/business/ct-marathon-muscular-dystrophy-drug-0119-biz-20150119-story.html#page=1
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Glucocorticoids
- Prodrugs
- Oxazolines
- Acetate esters
- Systemic hormonal preparation stubs